Maury Raycroft

Stock Analyst at Jefferies

(1.60)
# 3,425
Out of 5,182 analysts
59
Total ratings
35.56%
Success rate
-2.2%
Average return

Stocks Rated by Maury Raycroft

Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32$43
Current: $35.06
Upside: +22.65%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66$81
Current: $83.67
Upside: -3.19%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114$63
Current: $24.53
Upside: +156.83%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7$0.5
Current: $0.28
Upside: +79.66%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108$134
Current: $120.07
Upside: +11.60%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10$21
Current: $16.04
Upside: +30.92%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2$1.6
Current: $1.21
Upside: +32.23%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550$549
Current: $302.11
Upside: +81.72%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18$7
Current: $7.31
Upside: -4.24%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $45.43
Upside: -66.98%
Initiates: Hold
Price Target: $3.5
Current: $1.68
Upside: +108.33%
Maintains: Buy
Price Target: $70$53
Current: $9.82
Upside: +439.71%
Maintains: Buy
Price Target: $7$8
Current: $1.84
Upside: +334.78%
Maintains: Buy
Price Target: $7$3
Current: $0.20
Upside: +1,392.54%
Initiates: Buy
Price Target: $6
Current: $9.90
Upside: -39.39%
Initiates: Buy
Price Target: $19
Current: $25.14
Upside: -24.42%
Assumes: Buy
Price Target: $23$15
Current: $3.69
Upside: +306.50%
Initiates: Buy
Price Target: $180
Current: $12.46
Upside: +1,345.20%
Initiates: Buy
Price Target: $23
Current: $1.44
Upside: +1,497.22%
Initiates: Buy
Price Target: $195
Current: $1.69
Upside: +11,438.46%
Upgrades: Buy
Price Target: $11
Current: $8.86
Upside: +24.15%
Downgrades: Hold
Price Target: $32$6
Current: $37.11
Upside: -83.83%
Maintains: Buy
Price Target: $92$75
Current: $70.13
Upside: +6.94%
Initiates: Buy
Price Target: $11
Current: $3.07
Upside: +258.31%
Downgrades: Hold
Price Target: $38$5
Current: $1.53
Upside: +226.80%
Initiates: Buy
Price Target: $36
Current: $5.53
Upside: +550.99%
Initiates: Buy
Price Target: $105
Current: $7.45
Upside: +1,309.40%
Upgrades: Buy
Price Target: $172
Current: $52.06
Upside: +230.39%
Initiates: Buy
Price Target: $47
Current: $2.70
Upside: +1,640.74%
Maintains: Buy
Price Target: $36$42
Current: $13.20
Upside: +218.18%